|
C6ORF167 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.751400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.356600E-01 |
| Normal-vs-Stage2 |
6.342400E-03 |
| Normal-vs-Stage3 |
1.985790E-01 |
| Normal-vs-Stage4 |
1.433030E-01 |
| Stage1-vs-Stage2 |
5.537800E-03 |
| Stage1-vs-Stage3 |
4.392400E-01 |
| Stage1-vs-Stage4 |
3.548600E-01 |
| Stage2-vs-Stage3 |
9.034000E-02 |
| Stage2-vs-Stage4 |
1.795580E-01 |
| Stage3-vs-Stage4 |
7.493600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.530000E-01 |
| Normal-vs-AfricanAmerican |
6.567200E-01 |
| Normal-vs-Asian |
1.874640E-01 |
| Caucasian-vs-AfricanAmerican |
8.787800E-01 |
| Caucasian-vs-Asian |
5.065800E-01 |
| AfricanAmerican-vs-Asian |
5.559800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.712000E-01 |
| Normal-vs-Female |
1.184630E-01 |
| Male-vs-Female |
3.947800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.971200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.496400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.886330E-02 |
| Normal-vs-Age(81-100Yrs) |
3.847400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.397500E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.862900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.318600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.281800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.784400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.284800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.848200E-01 |
| Classical-VS-Follicular |
1.0862999999528E-07 |
| Classical-VS-Other |
6.901200E-01 |
| Classical-VS-Normal |
7.390800E-01 |
| Tall-VS-Follicular |
1.882890E-03 |
| Tall-VS-Other |
6.997400E-01 |
| Tall-VS-Normal |
8.027400E-01 |
| Follicular-VS-Other |
1.864440E-01 |
| Follicular-VS-Normal |
3.761700E-04 |
| Other-VS-Normal |
6.025600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.981600E-03 |
| Normal-vs-N1 |
3.820600E-01 |
| N0-vs-N1 |
1.376020E-01 |
|
|
